Related Experiment Video
Updated: Feb 12, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Thrombocytopenia and Bleeding in Patients With Oncologic Emergencies Following Cancer Therapy
Le Tian1, Jia-Xin Huang1, Xi Zhang1
1Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Cancer therapy-induced thrombocytopenia (CTIT) affects 13.5% of emergency oncology patients. Fever and pleural effusion are key risk factors for CTIT-related bleeding, necessitating increased clinical vigilance.
Area of Science:
- Oncology
- Hematology
- Emergency Medicine
Background:
- Cancer therapy-induced thrombocytopenia (CTIT) is a significant complication.
- Limited data exists on CTIT-related hemorrhage risk factors in emergency oncology patients, particularly from China.
Purpose of the Study:
- To investigate the incidence and risk factors for CTIT and associated organ hemorrhage in Chinese emergency oncology patients.
- To identify predictors of CTIT-related bleeding.
Main Methods:
- Retrospective study of 8590 emergency oncology visits.
- Analysis of clinical features and outcomes for 1164 patients with CTIT.
- Identification of independent risk factors for CTIT and hemorrhage.
Main Results:
- CTIT occurred in 13.5% of patients (1164/8590).
- Organ hemorrhage was observed in 5.24% of CTIT cases (61/1164).
- Independent risk factors for CTIT deterioration included ECOG score 2-4, stage IV malignancy, organ bleeding, anemia, and fever.
- Independent risk factors for CTIT-related bleeding were fever (OR=4.886) and pleural effusion (OR=4.812).
- Lung cancer was the most common malignancy (41%) among bleeding cases.
Conclusions:
- Malignancies leading to reduced platelet counts, coupled with specific risk factors, demand heightened clinical attention for hemorrhage.
- Fever and pleural effusion are critical indicators for predicting bleeding risk in CTIT patients.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Emerging Adulthood
Bleeding in Fresh Concrete
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
Introduction Cardiac Emergencies
Gene Therapy

